Antoine Papiernik

Biography

 Mr. Antoine Papiernik-Berkhauer, MBA has been Managing Partner of the Sofinnova Partners since joining in 1997. Mr. Papiernik-Berkhauer also serves as Chairman and President at the firm. He is responsible for life sciences, biopharmaceuticals, industrial biotechnology and medical devices sectors. He worked at CDC-Innovation. He served as an Investment Manager of CDC Entreprises Capital Investissement. He was employed at Unilever plc and Innovation Capital SAS. He served as the Chairman of PRO-MED, Medizinische Produktions- und Handels-AG. He is an initial investor and active board member in companies like Actelion, EuroNext Paris and Cotherix. He has been a Non-Executive Director at Mainstay Medical International plc since April 3, 2014. He has been a Director of RefleXion Medical Inc. since April 3, 2014. Mr. Papiernik-Berkhauer serves as a Director of MD Start SA; Shockwave Medical, Inc., and ReCor Medical, Inc. He has been a Member of Supervisory Board at ProQR Therapeutics N.V. since January 1, 2014. He has been a Director of Auris Medical Holding AG since April 2013. He has been a Director of Gecko Biomedical SAS since March 17, 2016 and Rgenix, Inc. since June 15, 2016. He serves as a Director of Movetis. He serves as a Director of CoAxia, Inc. Mr. Papiernik-Berkhauer served as a Director of EOS (Ethical Oncology Science) S.p.A. and Novuspharma SpA. He has been Board Observer at Pixium Vision SA since June 27, 2017 and served as its Director from November 2013 to June 27, 2017. He served as a Director at Addex Therapeutics Ltd. until March 19, 2013 and STENTYS Société anonyme until January 27, 2016. He served as a Director of Fovea Pharmaceuticals SA, Allergan Medical Sàrl, PRO-MED Medizinische Produktions- und Handels-AG, Medtronic CoreValve LLC. He served as a Director of Biolipox AB since 2001. Mr. Papiernik-Berkhauer served as a Director of DIATOS S.A., SpineVision S.A. and Biovector Therapeutics SA. He served as a Non-Executive Director of Shire-Movetis NV since June 27, 2007. He served as a Director of Orexo AB from November 13, 2007 to 2008. He served as a Director of Lectus Therapeutics Limited. He has an extensive track record as investor and board member of private companies. He is one of the only Europeans on the list and one of the few life science investors as well. For 2012 and 2011, he has been recognized on the Forbes "Midas List" of the worldwide top dealmakers in life-science and high-tech venture capital. Mr. Papiernik-Berkhauer holds an M.B.A. from the Wharton School of Business, University of Pennsylvania.

Research Interest

 Bussiness Investment and Development